Data / Form D filings / SPECTRUM PHARMACEUTICALS INC
SPECTRUM PHARMACEUTICALS INC: Form D filings
SPECTRUM PHARMACEUTICALS INC, a pharmaceuticals company in Henderson, NV, filed 2 Form D notices with the SEC between 2013 and 2016. The latest, on April 28, 2016, reports $3 million sold of a $3 million offering to 1 investor.
Find out what SPECTRUM PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11500 S. EASTERN AVE., SUITE 240, Henderson, NV, 89052
- Phone
- (702) 835-6300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 831547
The full lists. Form D filings in Nevada: 610 rows, $30.50, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2016 | New notice | $3,000,000 | $3,000,000 | $0 | 1 | Apr 26, 2016 | sec.gov |
| Jul 31, 2013 | New notice | $27,500,000 | $27,500,000 | $0 | 4 | Jul 17, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anthony E. Maida | Director | |
| Gilles R. Gagnon | Director | |
| Stuart M. Krasner | Director | |
| Luigi M. Lenaz | Director | |
| Rajesh C. Shrotriya | Executive Officer, Director | |
| Raymond W. Cohen | Director | |
| Kurt A. Gustafson | Executive Officer | |
| Joseph W. Turgeon | Executive Officer | |
| Dolatrai R. Vyas | Director |
Every Form D from the week of Apr 25, 2016 · All recent filings in Nevada · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SPECTRUM PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.